Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Envisioning the Future of the Pharmaceutical Supply Chain
Through a collaboration with the Milken Institute, HDA, along with diverse thought leaders and experts, provided expertise to inform a new report from the Milken Institute’s Center for Public Health. The report “Envisioning the Future of the Pharmaceutical Supply Chain to Advance Public Health in the United States,” emphasizes how a resilient pharmaceutical supply chain bolsters a strong public health infrastructure in the U.S, and brings a greater focus and awareness into supply chain collaboration to create an enhanced public health environment that is equitable, sustainable and resilient.
Advocacy in Action: TopRx Provides On-the-Ground Perspective During Rep. Kustoff’s Facility Visit
On May 4, HDA distributor member company TopRx gave a tour of their headquarters in Bartlett, Tenn., to Representative David Kustoff (R-Tenn.-08).
Member Spotlight: When Distribution Is a Family Calling
While the business of pharmaceutical distribution has changed significantly over the past eight decades, HDA members like Capital Wholesale Drug Company (Capital Drug) have continued to play an essential role in providing safe and efficient healthcare delivery to trusted pharmacists and providers.
HDA Guidelines for Bar Coding in the Pharmaceutical Supply Chain
This comprehensive guideline, developed by the distribution-sector experts of HDA’s Bar Code Task Force, provides specifications for bar coding and labeling healthcare products.